A bill to add the Health Insurance Review and Assessment Service to the post-notification subjects for dispensing substitute drugs by pharmacists is scheduled to be reviewed on the 21st, but the government's cautious stance is expected to be a hurdle.

The Ministry of Health and Welfare has not changed its stance on the bill, saying it should be carefully reviewed considering the scope of the HIRA’s work and concerns about the safety of drug use caused by the increased notification term.

Physicians and hospital organizations are also opposed to the expansion of post-notification, citing concerns that it would undermine the doctors' prescription rights and delay the time of notification